Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 15, 2009

View Archived Issues

Dapagliflozin improves glycemic control in type 2 diabetes patients and in preclinical models

Celator completes enrollment in phase II clinical trial of CPX-351 in untreated AML

Signs of activity seen with PTC-299 in metastatic breast cancer patients

Trigone-specific injection of botulinum toxin type B improves idiopathic detrusor overactivity

Long-term improvements in signs of vaginal atrophy seen with ospemifene

Clinical data support safety and efficacy of S-equol in postmenopausal women

Nicorandil improves clinical outcomes in acute ST segment elevation myocardial infarction

Vaccine to treat cocaine dependence evaluated in phase IIb study / News in Context

Aquinox selects AQX-1125 as lead clinical candidate in SHIP program

Vanda and Novartis sign agreement for antipsychotic Fanapt in the U.S. and Canada

BioMimetic Therapeutics presents topline data from its Augment Bone Graft trial

Phytopharm reports results for Cogane in Parkinson's disease

EMEA grants orphan drug designation to ARQ-197 for soft tissue sarcoma

Myriad identifies IND candidate targeting IKK epsilon

Pieris reports preclinical development of VEGF antagonist PRS-050

OPKO Health acquires lead NK1 compounds from Schering-Plough

Newron returns rights to HF-0420 and pursues development of HF-0220

Depomed reports results of phase III trials of Serada for menopausal hot flashes

Raptor reports interim results from phase IIa clinical trial of DR cysteamine in NASH

Inovio Biomedical reports results on SynCon A/H1N1 influenza vaccine

CSL donates 3 million doses of pandemic influenza A (H1N1) vaccine to WHO

European Commission grants marketing authorization to Boehringer's Sifrol for PD

BMS describes NS5A protein inhibitors for the treatment of HCV infection

Servier claims dual nitric oxide donors and diuretic agents for treating hypertension

German scientists report EGFR and HER2 tyrosine kinase inhibitors for cancer treatment

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...